MENU
GDOC
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

GDOC stock forecast, quote, news & analysis

The investment seeks long-term growth of capital... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
GDOC
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for GDOC with price predictions
Oct 21, 2026

Momentum Indicator for GDOC turns positive, indicating new upward trend

GDOC saw its Momentum Indicator move above the 0 level on October 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In 68 of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for GDOC just turned positive on October 19, 2026. Looking at past instances where GDOC's MACD turned positive, the stock continued to rise in 35 of 49 cases over the following month. The odds of a continued upward trend are 71%.

GDOC moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where GDOC advanced for three days, in 180 of 234 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

GDOC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for GDOC crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for GDOC entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), Guardant Health (NASDAQ:GH).

Industry description

The investment seeks long-term growth of capital. The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non‑U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.

Market Cap

The average market capitalization across the Future Health Care Equity ETF (GDOC) ETF is 96.38B. The market cap for tickers in the group ranges from 1.2B to 1.13T. LLY holds the highest valuation in this group at 1.13T. The lowest valued company is KARD at 1.2B.

High and low price notable news

The average weekly price growth across all stocks in the Future Health Care Equity ETF (GDOC) ETF was 23%. For the same ETF, the average monthly price growth was 23%, and the average quarterly price growth was 210%. SYRE experienced the highest price growth at 18%, while KARD experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Future Health Care Equity ETF (GDOC) ETF was 12%. For the same stocks of the ETF, the average monthly volume growth was 15% and the average quarterly volume growth was -8%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 42
Price Growth Rating: 43
SMR Rating: 65
Profit Risk Rating: 70
Seasonality Score: 29 (-100 ... +100)
Momentum Indicator for GDOC turns positive, indicating new upward trend